[HTML][HTML] Current progress in xenotransplantation and organ bioengineering

SG Michel, MLL Madariaga, V Villani… - International Journal of …, 2015 - Elsevier
Organ transplantation represents a unique method of treatment to cure people with end-
stage organ failure. Since the first successful organ transplant in 1954, the field of …

The vascular and coagulation issues in xenotransplantation

PJ Cowan, JC Roussel, AJF d'Apice - Current Opinion in Organ …, 2009 - journals.lww.com
The vascular and coagulation issues in xenotransplantation : Current Opinion in Organ
Transplantation The vascular and coagulation issues in xenotransplantation : Current Opinion …

Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going?

L Antonovic, M Martinez - Future Medicinal Chemistry, 2011 - Taylor & Francis
Drug metabolism is a core determinant of the dose–effectiveness–toxicity relationship of
many compounds. It is also critical to the human food safety assessment of drug residues in …

Modified glycan models of pig-to-human xenotransplantation do not enhance the human-anti-pig T cell response

JR Butler, ZY Wang, GR Martens, JM Ladowski… - Transplant …, 2016 - Elsevier
Genetically modified porcine models of pig-to-human xenotransplantation offer the most
immediate answer to a growing shortage of available solid organs. Recently a modified …

[图书][B] Animal by-products (ABPs): origins, uses, and European regulations

R Leoci - 2014 - books.google.com
In theory, about 95% of one animal is usable. The remaining 5% is processing losses. From
that 95%, about 55%(on average) of the animal is used for edible products and the …

Double transgenic pigs with combined expression of human α1, 2-fucosyltransferase and α-galactosidase designed to avoid hyperacute xenograft rejection

J Zeyland, A Woźniak, B Gawrońska, W Juzwa… - Archivum immunologiae …, 2014 - Springer
Hyperacute rejection (HAR) depends on the response of xenoreactive antibodies principally
against porcine α-Gal epitope. Methods eliminating HAR include GGTA1 inactivation …

Validation of xCELLigence real-time cell analyzer to assess compatibility in xenotransplantation with pig-to-baboon model

JJ Quereda, L Martinez-Alarcon, L Mendoça… - Transplantation …, 2010 - Elsevier
OBJECTIVE: To validate the use of a microelectronic real-time cell analyzer system (RTCA)
we developed a complement-mediated antibody cytotoxicity assay to investigate the …

T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons

EM Dons, C Montoya, CE Long, H Hara… - …, 2012 - journals.lww.com
Background. We set out to determine whether B-cell tolerance to A/B-incompatible
alloantigens and pig xenoantigens could be achieved in infant baboons. Methods. Artery …

Suboptimal porcine endogenous retrovirus infection in non-human primate cells: implication for preclinical xenotransplantation

G Mattiuzzo, Y Takeuchi - PLoS One, 2010 - journals.plos.org
Background Porcine endogenous retrovirus (PERV) poses a potential risk of zoonotic
infection in xenotransplantation. Preclinical transplantation trials using non-human primates …

Genetic modification of pigs for solid organ xenotransplantation

H Gock, M Nottle, AM Lew, AJF d'Apice, P Cowan - Transplantation reviews, 2011 - Elsevier
Xenotransplantation of solid organs will only ever become a clinical reality with genetic
modification of the pig, which is now widely accepted as the most likely donor species for …